Bayer HealthCare, of Wayne, announced it received federal approval for its treatment of certain types of tumors.
In the announcement, Bayer said its Stivarga tablets, which are jointly produced by Bayer and Onyx Pharmaceuticals, of South San Francisco, Calif., were approved by the Food and Drug Administration to treat certain gastrointestinal tumors. The FDA approved the drug in September to treat patients with certain colon cancers. Bayer has been putting a focus on its oncology pipeline.
Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.View Comment Policy